All Substitutes


Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
PERJETA 420MG INJECTION_1
PERJETA 420MG INJECTION_2
PERJETA 420MG INJECTION_1
14% Off

Perjeta 420mg Injection

Prescription Required

cold-chain

Salt Composition : Pertuzumab

Manufacturer : ROCHE PRODUCTS INDIA PVT LTD

Origin of Medicine : Switzerland

MRP: 275562
Price :236570
You Save :38992 (14%)

1 Vial(s) Of 14ml

Prepaid Only. Non-Returnable

PAP Information :    Buy 1, Get 1 Free. Contact us for latest updates.


Patient Assistance Programs
Know About PAP

Program Overview: ROCHE PRODUCTS INDIA PVT LTD, is dedicated to helping patients in need of Perjeta 420mg injection. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Purchase 1 vial of Perjeta 420mg injection, and you will receive 1 free additional vial. Therefore, if eligible, you will have to pay only Rs. 2,36,570 for two vials, which is Rs. 1,18,285 per vial. 

With MrMed's MRP discount of Rs. 38,992 per vial and Pfizer’s PAP program, the overall savings is over Rs. 3 lakhs per purchase. 

Eligibility Criteria: To qualify for the Perjeta Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Pertuzumab 420mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Roche can avail of it without having to purchase the medication from MrMed.

Patient Assistance Programs

Program Overview: ROCHE PRODUCTS INDIA PVT LTD, is dedicated to helping patients in need of Perjeta 420mg injection. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Purchase 1 vial of Perjeta 420mg injection, and you will receive 1 free additional vial. Therefore, if eligible, you will have to pay only Rs. 2,36,570 for two vials, which is Rs. 1,18,285 per vial. 

With MrMed's MRP discount of Rs. 38,992 per vial and Pfizer’s PAP program, the overall savings is over Rs. 3 lakhs per purchase. 

Eligibility Criteria: To qualify for the Perjeta Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Pertuzumab 420mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Roche can avail of it without having to purchase the medication from MrMed.

Introduction to Perjeta 420mg Injection

Perjeta 420mg Injection is an anticancer medication containing the active constituent Pertuzumab. It is used to treat a type of breast cancer (HER2-positive breast cancer) in combination with other chemotherapy medications. Cancer is a condition in which cells multiply uncontrolled and abnormally.

Perjeta 420mg Injection is not recommended for adolescents and children under 18 years of age. Before taking this medicine, it is vital to inform your doctor if you have or have ever had heart problems or chemotherapy. Use effective birth control during the treatment and for at least six months after the last dose. 

Inform your doctor if you have kidney disease before starting with this Pertuzumab injection. Patients with kidney disease should cautiously use this medicine. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medicine. Do not stop taking this medication without talking to your physician first. 


Uses of Perjeta 420mg Injection

  • HER2-positive breast cancer

Therapeutic Effects of Perjeta 420mg Injection

Perjeta 420mg binds to the human epidermal growth factor receptor 2 (HER2) on cancer cells, potentially destroying or inhibiting cancer cell growth.


Interaction of Perjeta 420mg Injection with other drugs

Inform your healthcare provider about all your medicines, including prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Perjeta 420mg and reduce effectiveness by causing undesirable side effects.  


More Information about Perjeta 420mg Injection

  • Keep Perjeta 420mg Injection out of sight and reach of children.
  • Store in refrigerator at 2°C to 8°C. Do not freeze.

How to consume Perjeta 420mg Injection

Perjeta 420mg Injection is available as an injection and administered intravenously once every three weeks. Follow your physician's instructions. Your doctor will determine the frequency and dose of administration because it varies for each person depending on the disease condition. Don’t self-administer. 


Safety Advices for Perjeta 420mg Injection

Image Not Available  

Pregnancy

  

Inform your doctor in case you are pregnant, think you might be pregnant or are planning to get pregnant, as Perjeta 420mg injection may be unsafe during pregnancy.

Image Not Available  

Breast Feeding

  

It may be unsafe to take Perjeta 420mg Injection while breastfeeding. Consult your doctor if you are breastfeeding before taking this medication. 

Image Not Available  

Lungs

  

It is unknown whether Perjeta 420mg Injection is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.

Image Not Available  

Liver

  

Perjeta 420mg Injection is used with caution in patients with liver impairment. Inform your physician about the pre-existing live conditions. Your physician will monitor your liver functions and adjust the dose accordingly.

Image Not Available  

Alcohol

  

 It is not known whether it is safe to consume alcohol with Perjeta 420mg injection. Please consult your doctor.

Image Not Available  

Driving

  

Perjeta 420mg injection may cause dizziness, infusion reaction, and other minor effects. So,  avoid driving if you are unwell.


Side Effects of Perjeta 420mg Injection

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. 

Serious

  • Severe or persistent diarrhea
  • Low white blood cell count
  • Infusion reactions (fever, chills, hot flushes, nausea, headache, joint, and muscle pain)
  • Severe allergic reactions (swelling of throat and face, difficulty in breathing)
  • Heart problems (cough, swelling in arms or legs, shortness of breath)
  • Tumour lysis syndrome (confusion, tiredness, irregular heartbeat, seizures, tingling sensation)

Common

  • Hair loss
  • Rash
  • Sore mouth
  • Constipation
  • Poor appetite
  • Changes in taste
  • Sleeping troubles
  • Nose bleeds
  • Heartburn
  • Nail problems
  • Producing more tears
  • Feeling dizzy
  • Dry and itchy skin
  • Ear, nose, or throat infection

Word of Advice

Perjeta 420mg can cause heart problems like heart failure,  irregular heartbeats, and uncontrolled high blood pressure. So inform your doctor about your medical history before starting with the treatment. If you experience any symptoms mentioned above, consult your doctor immediately. While undergoing treatment, use effective contraception and continue it for six months after stopping treatment.


FAQs

Q 1. Does Perjeta 420mg cause any heart problems?

Perjeta 420mg can damage the heart muscle and increase the risk of heart problems. Notify your doctor if you have any history of heart problems.

Q 2. Should I use contraception even after the treatment with Perjeta 420mg?

Yes, Using contraception during and after treatment with Perjeta 420mg injection for at least six months is necessary.

Q 3. Can Pertuzumba be self-administered?

No, Pertuzumba should not be self-administered and must be given only under the supervision of a healthcare professional.

Q 4. What should I tell my doctor before taking the Perjeta 420mg injection?

Inform your doctor about the history of your high blood pressure, irregular heartbeat, heart failure, and other heart-related problems.

Q 5. Is it okay to take new medication while taking Perjeta 420mg?

Inform your doctor about the list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use because certain medications may interact with Perjeta 420mg and reduce effectiveness by causing undesirable side effects.


Fact Box of Perjeta 420mg Injection

 

Molecule name:  Pertuzumab 

Therapeutic class:  Antineoplastics

Pharmacological class: Monoclonal antibody (mAb)

Indications: Treatment of HER2-positive breast cancer


References

  1. Roche Products Ltd, Electronic medicines compendium (emc), [Revised on January 2022] [ Accessed on 15 March 2023], https://www.medicines.org.uk/emc/files/pil.2993.pdf
  2. PERJETA,U.S Food & Drug Administration FDA, [Revised on Jun 2012],[Accessed on15 March 2023],https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125409lbl.pdf
  3. Komal Jhaveri, Francisco J Esteva; Pertuzumab in the treatment of HER2+ breast cancer; Journal of the National Comprehensive Cancer Network; Published on April 2014; Accessed on 15 March 2023; https://pubmed.ncbi.nlm.nih.gov/24717573/  
  4. Kei Ishii; Pertuzumab in the treatment of HER2-positive breast cancer: An evidence-based review of its safety, efficacy, and place in therapy; [Published online on 31st Oct 2019];[Accessed on 21st Feb 2023];  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827570

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.

4000+ products

We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.

Secure Payment

100% secure and trusted payment protection

Easy Return

We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.